🇧🇪 Belgium Country × Condition
ulcerative colitis Clinical Trials in Belgium
Active clinical trials for ulcerative colitis with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇧🇪 Belgium
Active Trials in Belgium (4)
NCT05442567 Phase 3
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Enrollment
240 pts
Country
🇧🇪 Belgium
Takeda
View Trial → NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment
140 pts
Country
🇧🇪 Belgium
Eli Lilly and Company
View Trial → NCT06113913 Phase 4
Recruiting
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Enrollment
275 pts
Country
🇧🇪 Belgium
Belgian Inflammatory Bowel Disease ...
View Trial → NCT06865417 Phase 3
Recruiting
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Enrollment
80 pts
Country
🇧🇪 Belgium
Alfasigma S.p.A.
View Trial → Frequently Asked Questions
How many ulcerative colitis clinical trials are active in Belgium?
There are currently 4 active clinical trials for ulcerative colitis with sites in Belgium, of which 4 are actively recruiting patients.
How can I join a ulcerative colitis clinical trial in Belgium?
To join a ulcerative colitis clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ulcerative colitis trials in Belgium?
Active ulcerative colitis trials in Belgium span Phase 3, Phase 2, Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology